JP Patent

JP7083214B2 — 膵がんを治療する方法

Assigned to ケモセントリックス， インコーポレイテッド · Expires 2022-06-10 · 4y expired

What this patent protects

Patent listed against Zelboraf.

Drugs covered by this patent

Patent Metadata

Patent number
JP7083214B2
Jurisdiction
JP
Classification
—
Expires
2022-06-10
Drug substance claim
No
Drug product claim
No
Assignee
ケモセントリックス， インコーポレイテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.